Additionally, the intestinal microbiota's influence on bile acid metabolism, modulating farnesoid X receptor (FXR) stimulation, contributes to NAFLD pathogenesis by affecting de novo lipogenesis and VLDL export processes [54]. Here, NR1H4 is linked to metabolic dysfunction-associated steatotic liver disease.